Despite indications that US companies expect growth in revenue and profitability next year in China, concern about possible trade actions was evident in polling USCBC members who attended the Shanghai China Operations Conference on November 30.
China Market Intelligence
Chinese regulations on tendering and bidding practices published by the Ministry of Finance (MOF) in July are a promising sign for US pharmaceutical and medical device manufacture
The US-China Business Council (USCBC) recently submitted comments to the China Food and Drug Administration (CFDA) on the
Intellectual property (IP) theft and forced technology transfer are serious issues that need to be addressed in China, said Senior Vice President Erin Ennis in testimony about
Recently announced provincial reimbursement drug lists (PRDLs) provide possible new opportunities for US pharmaceutical companies seeking to expand market reach for their drugs in China.
Changes stemming from the implementation of China’s Food Safety Law threaten to block imports of a wide range of food products from countries unable to provide the necessary certificates.
As a temporary suspension expires this month, US companies’ concerns about China’s height limits on trucks came to the forefront of US-China Business Council (USCBC) advocacy efforts.
China’s internet and security regulators are ratcheting up enforcement of virtual private network (VPN) compliance to rein in uncensored access to the internet.
As China urbanizes, and workers move from factories to offices, the construction and operation of buildings will account for a growing share of Chinese cities’ energy consumption and carbon emissions.